We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

CRISPR and Genome Editing – News and Features

News

RNA Interference Knocks Down Prion Genes in Livestock

The strategy might be used to protect animals against influenza or foot-and-mouth disease.
News

Prediction of a Prokaryotic RNA-Silencing System

Researchers use computational methods to predict what could be a prokaryotic RNA-silencing mechanism similar to the eukaryotic RNAi system.
News

Research and Markets Adds Nanotechnology for Drug Discovery and Drug Design to Their offering

Nanotechnology drug-delivery companies seeking to partner with pharmaceutical companies face competition from a plethora of available drug-delivery systems.
News

CytRx Provides 2006 Update on RNAi-Based Drug Discovery Programs

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.
News

Gene to Screen Track at SCIpharm 2006 Aimed at the Biological Scientist

Now in its second year, the SCIpharm 2006 conference (May 14-17, EICC, Edinburgh, Scotland) will cover all aspects of modern R&D in a four-track format - Gene to Screen, Screen to Candidate, Candidate to Drug and Where Science Meets Business.
News

RheoGene Grants Ichor License to Develop a Regulated Gene Therapy

Ichor has granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.
News

Significant Technological Challenges Remain for the Development of RNA-Based Therapeutics

In this Decision Resources report three RNA-based technologies are described.
News

Researchers Develop Remote Control Gene Expression Tool

This versatile package can carry bits of RNA that stop the cell from expressing one of its own genes.
News

Sigma-Aldrich Expands shRNA Libraries of the RNAi Consortium

The collection now carries 65,000 shRNA vector constructs that target 9,500 human genes and 3,400 mouse genes.
News

Lentigen and ZGene Enter License Agreement for Selected ZGene Intellectual Property

Lentigen gains exclusive, world-wide license to multisubstrate kinase gene technology.
Advertisement